DevCo Appoints Heli Leskinen as Partner

20 January 2026, Helsinki, Finland – DevCo Partners is pleased to announce the appointment of Heli Leskinen as Partner.

Heli joined DevCo in 2022 as Chief Financial Officer, bringing substantial M&A and broad finance experience. Since joining DevCo, she has played a central role in the firm’s development and success. Heli has actively contributed to the growth journey of DevCo by leading the development of DevCo’s operations and several strategic initiatives, driving a step-change in DevCo’s sustainability efforts, and being closely involved in the significant capital raises for Medix Biochemica and Vexve.

“We are excited to welcome Heli as a Partner at DevCo as we continue to build DevCo into a global leader in long-term single-platform investments in high-quality medium-sized companies. Heli has made a significant contribution to the success of DevCo and our companies through her exceptional drive and genuine commitment to our mission and values. Her hands-on mindset and ability to combine world-class execution with trust and openness make her an excellent fit for the partnership.”

says Juhani Laakso, Partner at DevCo Partners.

‍DevCo in brief
‍DevCo Partners is a long-term oriented active owner dedicated to building world-leading companies in selected niche markets. DevCo provides its companies with hands-on operational resources, strategic support and significant financial resources to support step changes in their performance. DevCo is currently a significant owner of three global niche leaders – Vexve, Medix Biochemica, and Bluefors.

‍